These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1932613)

  • 1. Pharmacokinetics of diltiazem and propranolol when administered alone and in combination.
    Dimmitt DC; Yu DK; Elvin AT; Giesing DH; Lanman RC
    Biopharm Drug Dispos; 1991 Oct; 12(7):515-23. PubMed ID: 1932613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diltiazem pharmacokinetics in elderly volunteers after single and multiple doses.
    Caillé G; Boucher S; Spénard J; Lakhani Z; Russell A; Thiffault J; Grace MG
    Eur J Drug Metab Pharmacokinet; 1991; 16(2):75-80. PubMed ID: 1936076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of diltiazem in patients with liver cirrhosis.
    Kurosawa S; Kurosawa N; Owada E; Soeda H; Ito K
    Int J Clin Pharmacol Res; 1990; 10(6):311-8. PubMed ID: 2099357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state pharmacokinetics of diltiazem and hydrochlorothiazide administered alone and in combination.
    Weir SJ; Dimmitt DC; Lanman RC; Morrill MB; Geising DH
    Biopharm Drug Dispos; 1998 Sep; 19(6):365-71. PubMed ID: 9737817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic changes of diltiazem and desacetyldiltiazem after oral administration of diltiazem in rabbits with diabetes mellitus induced by alloxan.
    Choi JS; Kim YG
    Biopharm Drug Dispos; 2002 Apr; 23(3):115-20. PubMed ID: 12173546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald D
    Clin Pharmacol Drug Dev; 2014 Sep; 3(5):378-87. PubMed ID: 27129011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diltiazem pharmacokinetics in elderly volunteers after single and multiple doses.
    Caillé G; Boucher S; Spénard J; Lakhani Z; Russell A; Thiffault J; Grace MG
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):75-80. PubMed ID: 1936065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of diltiazem and its major metabolite, deacetyidiltiazem after oral administration of diltiazem in mild and medium folate-induced renal failure rabbits.
    Choi JS; Lee JH; Burm JP
    Arch Pharm Res; 2001 Aug; 24(4):333-7. PubMed ID: 11534767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of multiple doses of ranitidine on the pharmacokinetics and metabolism of diltiazem in dogs.
    Yeung PK; Mosher SJ; Landriault H
    Biopharm Drug Dispos; 1994 Apr; 15(3):207-15. PubMed ID: 7880981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of administration route and length of exposure on pharmacokinetics and metabolism of diltiazem in dogs.
    Yeung PK; Feng JD; Buckley SJ
    Drug Metabol Drug Interact; 2001; 18(3-4):251-62. PubMed ID: 11791888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite.
    Zhang X; Quinney SK; Gorski JC; Jones DR; Hall SD
    Drug Metab Dispos; 2009 Aug; 37(8):1587-97. PubMed ID: 19420129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Hong SP; Chang KS; Choi DH; Choi JS
    Arch Pharm Res; 2007 Jan; 30(1):90-5. PubMed ID: 17328247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure.
    Lee YH; Lee MH; Shim CK
    Pharm Res; 1992 Dec; 9(12):1599-606. PubMed ID: 1488404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C; Choi JS
    Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state pharmacokinetics of high-dose diltiazem hydrochloride (Cardizem CD) administered once daily in healthy volunteers.
    Robbins-Weilert DK; Giesing DH; Weir SJ
    Am J Ther; 1999 Jul; 6(4):211-6. PubMed ID: 11329099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and metabolism of diltiazem in rats: comparing single vs repeated subcutaneous injections in vivo.
    Yeung PK; Alcos A; Tang J; Tsui B
    Biopharm Drug Dispos; 2007 Oct; 28(7):403-7. PubMed ID: 17668417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phenobarbital pretreatment on the pharmacokinetics and metabolism of diltiazem in rats.
    Yeung PK; Buckley SJ; Cameron R; Feng JD; Jordan J
    Drug Metabol Drug Interact; 1996; 13(1):29-39. PubMed ID: 8902429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration.
    Sista S; Lai JC; Eradiri O; Albert KS
    J Clin Pharmacol; 2003 Oct; 43(10):1149-57. PubMed ID: 14517197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose.
    Boyd RA; Chin SK; Don-Pedro O; Verotta D; Sheiner LB; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Oct; 46(4):408-19. PubMed ID: 2791444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.